BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31358787)

  • 1. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.
    Shi B; Akbari P; Pourafkari M; Iliuta IA; Guiard E; Quist CF; Song X; Hillier D; Khalili K; Pei Y
    Sci Rep; 2019 Jul; 9(1):10996. PubMed ID: 31358787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging.
    Akbari P; Nasri F; Deng SX; Khowaja S; Lee SH; Warnica W; Lu H; Rattansingh A; Atri M; Khalili K; York P
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):827-834. PubMed ID: 35383043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.
    van Gastel MDA; Edwards ME; Torres VE; Erickson BJ; Gansevoort RT; Kline TL
    J Am Soc Nephrol; 2019 Aug; 30(8):1514-1522. PubMed ID: 31270136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.
    Kline TL; Korfiatis P; Edwards ME; Warner JD; Irazabal MV; King BF; Torres VE; Erickson BJ
    Nephrol Dial Transplant; 2016 Feb; 31(2):241-8. PubMed ID: 26330562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
    Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
    Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy and processing time of kidney volume measurement methods in rodents polycystic kidney disease models: superiority of semiautomated kidney segmentation.
    Doss MC; Mullen S; Roye R; Zhou J; Chumley P; Mrug E; Wallace DP; Qian F; Harris PC; Yoder BK; Kim H; Mrug M
    Am J Physiol Renal Physiol; 2023 Apr; 324(4):F423-F430. PubMed ID: 36794756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment.
    Turco D; Busutti M; Mignani R; Magistroni R; Corsi C
    Am J Nephrol; 2017; 45(5):373-379. PubMed ID: 28315882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease.
    Kim Y; Tao C; Kim H; Oh GY; Ko J; Bae KT
    J Am Soc Nephrol; 2022 Aug; 33(8):1581-1589. PubMed ID: 35768178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.
    van Gastel MDA; Messchendorp AL; Kappert P; Kaatee MA; de Jong M; Renken RJ; Ter Horst GJ; Mahesh SVK; Gansevoort RT;
    Abdom Radiol (NY); 2018 May; 43(5):1215-1222. PubMed ID: 28871393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited Performance of Estimated Total Kidney Volume for Follow-up of ADPKD.
    Demoulin N; Nicola V; Michoux N; Gillion V; Ho TA; Clerckx C; Pirson Y; Annet L
    Kidney Int Rep; 2021 Nov; 6(11):2821-2829. PubMed ID: 34805634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease.
    Dev H; Zhu C; Sharbatdaran A; Raza SI; Wang SJ; Romano DJ; Goel A; Teichman K; Moghadam MC; Shih G; Blumenfeld JD; Shimonov D; Chevalier JM; Prince MR
    J Magn Reson Imaging; 2023 Oct; 58(4):1153-1160. PubMed ID: 36645114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.
    Irazabal MV; Abebe KZ; Bae KT; Perrone RD; Chapman AB; Schrier RW; Yu AS; Braun WE; Steinman TI; Harris PC; Flessner MF; Torres VE;
    Nephrol Dial Transplant; 2017 Nov; 32(11):1857-1865. PubMed ID: 27484667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose.
    Bevilacqua MU; Hague CJ; Romann A; Sheitt H; Vasilescu DM; Yi TW; Levin A
    Radiology; 2019 Jun; 291(3):660-667. PubMed ID: 30964424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy, Reproducibility and User Experience With Standardized Instructions for Measurement of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease.
    Bevilacqua M; Hague CJ; Romann A; Levin A
    Can Assoc Radiol J; 2023 May; 74(2):343-350. PubMed ID: 36063401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
    Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
    Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.
    Irazabal MV; Rangel LJ; Bergstralh EJ; Osborn SL; Harmon AJ; Sundsbak JL; Bae KT; Chapman AB; Grantham JJ; Mrug M; Hogan MC; El-Zoghby ZM; Harris PC; Erickson BJ; King BF; Torres VE;
    J Am Soc Nephrol; 2015 Jan; 26(1):160-72. PubMed ID: 24904092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of total kidney volume in autosomal dominant polycystic kidney disease.
    Spithoven EM; van Gastel MD; Messchendorp AL; Casteleijn NF; Drenth JP; Gaillard CA; de Fijter JW; Meijer E; Peters DJ; Kappert P; Renken RJ; Visser FW; Wetzels JF; Zietse R; Gansevoort RT; ;
    Am J Kidney Dis; 2015 Nov; 66(5):792-801. PubMed ID: 26235803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated Kidney and Liver Segmentation in MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Study.
    Woznicki P; Siedek F; van Gastel MDA; Dos Santos DP; Arjune S; Karner LA; Meyer F; Caldeira LL; Persigehl T; Gansevoort RT; Grundmann F; Baessler B; Müller RU
    Kidney360; 2022 Dec; 3(12):2048-2058. PubMed ID: 36591351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease.
    Breysem L; De Rechter S; De Keyzer F; Smet MH; Bammens B; Van Dyck M; Hofmans M; Oyen R; Levtchenko E; Mekahli D
    Pediatr Nephrol; 2018 May; 33(5):827-835. PubMed ID: 29306987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.